Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support from the family physician, other primary care provider, community-based programs or referrals to specialist programs and services.
The global Chronic Diseases Management market was valued at US$ 1732.2 million in 2023 and is anticipated to reach US$ 3066.8 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
Long-term care centers and rehabilitation centers generally provide chronic disease management services. In chronic care management services, patient are aware of more reliable treatment options. Increase prevalence of chronic disease worldwide is the major factor of market growth for chronic disease management globally.
This report aims to provide a comprehensive presentation of the global market for Chronic Diseases Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Diseases Management.
Report Scope
The Chronic Diseases Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Diseases Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Diseases Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Diseases Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Diseases Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consulting Service
1.2.3 Implementation Service
1.3 Market by Application
1.3.1 Global Chronic Diseases Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Diseases Management Market Perspective (2019-2030)
2.2 Chronic Diseases Management Growth Trends by Region
2.2.1 Global Chronic Diseases Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Diseases Management Historic Market Size by Region (2019-2024)
2.2.3 Chronic Diseases Management Forecasted Market Size by Region (2025-2030)
2.3 Chronic Diseases Management Market Dynamics
2.3.1 Chronic Diseases Management Industry Trends
2.3.2 Chronic Diseases Management Market Drivers
2.3.3 Chronic Diseases Management Market Challenges
2.3.4 Chronic Diseases Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Diseases Management Players by Revenue
3.1.1 Global Top Chronic Diseases Management Players by Revenue (2019-2024)
3.1.2 Global Chronic Diseases Management Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Diseases Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Diseases Management Revenue
3.4 Global Chronic Diseases Management Market Concentration Ratio
3.4.1 Global Chronic Diseases Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Diseases Management Revenue in 2023
3.5 Chronic Diseases Management Key Players Head office and Area Served
3.6 Key Players Chronic Diseases Management Product Solution and Service
3.7 Date of Enter into Chronic Diseases Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Diseases Management Breakdown Data by Type
4.1 Global Chronic Diseases Management Historic Market Size by Type (2019-2024)
4.2 Global Chronic Diseases Management Forecasted Market Size by Type (2025-2030)
5 Chronic Diseases Management Breakdown Data by Application
5.1 Global Chronic Diseases Management Historic Market Size by Application (2019-2024)
5.2 Global Chronic Diseases Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Diseases Management Market Size (2019-2030)
6.2 North America Chronic Diseases Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Diseases Management Market Size by Country (2019-2024)
6.4 North America Chronic Diseases Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Diseases Management Market Size (2019-2030)
7.2 Europe Chronic Diseases Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Diseases Management Market Size by Country (2019-2024)
7.4 Europe Chronic Diseases Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Diseases Management Market Size (2019-2030)
8.2 Asia-Pacific Chronic Diseases Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Diseases Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Diseases Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Diseases Management Market Size (2019-2030)
9.2 Latin America Chronic Diseases Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Diseases Management Market Size by Country (2019-2024)
9.4 Latin America Chronic Diseases Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Diseases Management Market Size (2019-2030)
10.2 Middle East & Africa Chronic Diseases Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Diseases Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Diseases Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TriZetto Corporation
11.1.1 TriZetto Corporation Company Detail
11.1.2 TriZetto Corporation Business Overview
11.1.3 TriZetto Corporation Chronic Diseases Management Introduction
11.1.4 TriZetto Corporation Revenue in Chronic Diseases Management Business (2019-2024)
11.1.5 TriZetto Corporation Recent Development
11.2 Phytel
11.2.1 Phytel Company Detail
11.2.2 Phytel Business Overview
11.2.3 Phytel Chronic Diseases Management Introduction
11.2.4 Phytel Revenue in Chronic Diseases Management Business (2019-2024)
11.2.5 Phytel Recent Development
11.3 Pegasystems
11.3.1 Pegasystems Company Detail
11.3.2 Pegasystems Business Overview
11.3.3 Pegasystems Chronic Diseases Management Introduction
11.3.4 Pegasystems Revenue in Chronic Diseases Management Business (2019-2024)
11.3.5 Pegasystems Recent Development
11.4 AxisPoint Health
11.4.1 AxisPoint Health Company Detail
11.4.2 AxisPoint Health Business Overview
11.4.3 AxisPoint Health Chronic Diseases Management Introduction
11.4.4 AxisPoint Health Revenue in Chronic Diseases Management Business (2019-2024)
11.4.5 AxisPoint Health Recent Development
11.5 Wellcentive
11.5.1 Wellcentive Company Detail
11.5.2 Wellcentive Business Overview
11.5.3 Wellcentive Chronic Diseases Management Introduction
11.5.4 Wellcentive Revenue in Chronic Diseases Management Business (2019-2024)
11.5.5 Wellcentive Recent Development
11.6 Medecision
11.6.1 Medecision Company Detail
11.6.2 Medecision Business Overview
11.6.3 Medecision Chronic Diseases Management Introduction
11.6.4 Medecision Revenue in Chronic Diseases Management Business (2019-2024)
11.6.5 Medecision Recent Development
11.7 HealthSmart Holdings
11.7.1 HealthSmart Holdings Company Detail
11.7.2 HealthSmart Holdings Business Overview
11.7.3 HealthSmart Holdings Chronic Diseases Management Introduction
11.7.4 HealthSmart Holdings Revenue in Chronic Diseases Management Business (2019-2024)
11.7.5 HealthSmart Holdings Recent Development
11.8 Allscripts Healthcare Solutions
11.8.1 Allscripts Healthcare Solutions Company Detail
11.8.2 Allscripts Healthcare Solutions Business Overview
11.8.3 Allscripts Healthcare Solutions Chronic Diseases Management Introduction
11.8.4 Allscripts Healthcare Solutions Revenue in Chronic Diseases Management Business (2019-2024)
11.8.5 Allscripts Healthcare Solutions Recent Development
11.9 ZeOmega
11.9.1 ZeOmega Company Detail
11.9.2 ZeOmega Business Overview
11.9.3 ZeOmega Chronic Diseases Management Introduction
11.9.4 ZeOmega Revenue in Chronic Diseases Management Business (2019-2024)
11.9.5 ZeOmega Recent Development
11.10 Epic Corporation
11.10.1 Epic Corporation Company Detail
11.10.2 Epic Corporation Business Overview
11.10.3 Epic Corporation Chronic Diseases Management Introduction
11.10.4 Epic Corporation Revenue in Chronic Diseases Management Business (2019-2024)
11.10.5 Epic Corporation Recent Development
11.11 Harmony Information Systems
11.11.1 Harmony Information Systems Company Detail
11.11.2 Harmony Information Systems Business Overview
11.11.3 Harmony Information Systems Chronic Diseases Management Introduction
11.11.4 Harmony Information Systems Revenue in Chronic Diseases Management Business (2019-2024)
11.11.5 Harmony Information Systems Recent Development
11.12 Infosys
11.12.1 Infosys Company Detail
11.12.2 Infosys Business Overview
11.12.3 Infosys Chronic Diseases Management Introduction
11.12.4 Infosys Revenue in Chronic Diseases Management Business (2019-2024)
11.12.5 Infosys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research